United States · 
Who invested in Tentarix Biotherapeutics?
Tentarix Biotherapeutics's investors include Versant Ventures and Samsara BioCapital.
United States · Series B startup
Who invested in Tentarix Biotherapeutics
Funding summaryUpdated 26 Oct 2026
$35Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $35MSept 2023
- Investors
- 2
The rounds
- Sept 2023Series B$35M
Source recordedSEC filing: $35M sold, first sale Aug 2023
Founders and team
From Tentarix Biotherapeutics's own website and the SEC filings it signed: 8 on the team.
- Andy KiddChief Executive Officer
- Ankita SrivastavaSenior Vice President, Biotherapeutics
- Brady JohnsonSenior Vice President, Operations And Finance
- Ash KhannaChief Business Officer
- Margaret F. KarowChief Development Officer
- Stephen F. DemarestChief Scientific Officer
- Donald J. SantelIndependent Board Chairman
- Paul GraysonExecutive Officer, Directori
On the board, as filediAllyson F. TigheJerel DavisSrinivas AkkarajuThomas F. Bumol
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Tentarix Biotherapeutics
How much has Tentarix Biotherapeutics raised?
Tentarix Biotherapeutics has raised $35M across 1 round since 2023.
When did Tentarix Biotherapeutics last raise?
Tentarix Biotherapeutics's most recent round was a Series B of $35M in Sept 2023.
What was Tentarix Biotherapeutics's biggest round?
Its most recent round, $35M in Sept 2023, is also its largest on record.
Who backed Tentarix Biotherapeutics first?
Tentarix Biotherapeutics's first round on record, in Sept 2023, was backed by Versant Ventures and Samsara BioCapital.
What stage is Tentarix Biotherapeutics at?
Tentarix Biotherapeutics's latest named round is a Series B, in Sept 2023.
Where is Tentarix Biotherapeutics based?
Tentarix Biotherapeutics is based in the United States.
Companies like Tentarix Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.